Corcept Endocrinology President Sean Maduck disposes of USD 2.89 million in Corcept Therapeutics shares
Sean Maduck, President, Corcept Endocrinology, reported option exercises and share sales in Corcept Therapeutics. Exercised options for 25,000 shares at USD 8.27 on Oct. 1-2, 2026. * Sold 25,000 shares at weighted average prices of USD 115.5373 to USD 116.5534 on Oct. 1-2, 2026. Directly held 9,938 shares following the